Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Genetics and epigenetics

Diagnostics Genetics and epigenetics

Examining Sex-Dependent Psychiatric Risks

| Olivia Gaskill

Large-scale genome-wide genotype-by-sex interaction study finds sex-dependent risks of schizophrenia, bipolar disorder, and major depressive disorder

Diagnostics Genetics and epigenetics

Weighing Up the Genetic Risk of Lung Cancer

| Olivia Gaskill

Whole exome sequencing and endogenous DNA damage assays uncover deleterious germline variants associated with lung cancer susceptibility

Diagnostics Genetics and epigenetics

New e-book: The value of in-house genomic profiling for precision oncology!

| Sponsored by Thermo Fisher Scientific

Outside the Lab COVID-19

Weathering the Storm

| Michael Schubert

We sit down with Mike Osborn, President of the Royal College of Pathologists, to discuss pandemics, priorities, and the future of pathology

Diagnostics Analytical science

Tracing Plasma DNA Origins

| Olivia Gaskill

A new analysis shows potential for determining plasma DNA origins in prenatal testing, organ transplantation, and oncology

Diagnostics Analytical science

The Vast Potential of Single-Cell Analysis

| Zachary Pitluk

Zachary Pitluk outlines the route to single-cell analysis – and the promise it holds for human health and disease

Diagnostics Analytical science

Amplifying Biomarker Signals by Smartphone

| Olivia Gaskill

Detecting biomarkers at low concentrations is costly, sometimes inaccessible – could addressable nanoantennae on a smartphone microscope be the answer

Diagnostics Genetics and epigenetics

Let’s Do It Ourselves

| Sponsored by Thermo Fisher Scientific

Healthcare management and patient care both benefit when oncology biomarker testing is performed in-house

Diagnostics Genetics and epigenetics

One Giant Leap for Genomic Diversity

| Michael Schubert

A new study has sequenced 64 haplotypes representing 25 populations – moving human genome reference data closer to reflecting true human diversity

Diagnostics Genetics and epigenetics

A Comprehensive Answer for Cancer

| Sponsored by Thermo Fisher Scientific

Is comprehensive genomic profiling the next step in the evolution of genomics for oncology research and diagnostics?

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register